Literature DB >> 11371355

T cell-specific loss of Pten leads to defects in central and peripheral tolerance.

A Suzuki1, M T Yamaguchi, T Ohteki, T Sasaki, T Kaisho, Y Kimura, R Yoshida, A Wakeham, T Higuchi, M Fukumoto, T Tsubata, P S Ohashi, S Koyasu, J M Penninger, T Nakano, T W Mak.   

Abstract

PTEN, a tumor suppressor gene, is essential for embryogenesis. We used the Cre-loxP system to generate a T cell-specific deletion of the Pten gene (Pten(flox/-) mice). All Pten(flox/-) mice develop CD4+ T cell lymphomas by 17 weeks. Pten(flox/-) mice show increased thymic cellularity due in part to a defect in thymic negative selection. Pten(flox/-) mice exhibit elevated levels of B cells and CD4+ T cells in the periphery, spontaneous activation of CD4+ T cells, autoantibody production, and hypergammaglobulinemia. Pten(flox/-) T cells hyperproliferate, are autoreactive, secrete increased levels of Th1/Th2 cytokines, resist apoptosis, and show increased phosphorylation of PKB/Akt and ERK. Peripheral tolerance to SEB is also impaired in Pten(flox/-) mice. PTEN is thus an important regulator of T cell homeostasis and self-tolerance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11371355     DOI: 10.1016/s1074-7613(01)00134-0

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  233 in total

1.  Phosphatase and tensin homologue (PTEN) regulates synaptic plasticity independently of its effect on neuronal morphology and migration.

Authors:  Margaret Sperow; Raymond B Berry; Ildar T Bayazitov; Guo Zhu; Suzanne J Baker; Stanislav S Zakharenko
Journal:  J Physiol       Date:  2011-12-06       Impact factor: 5.182

Review 2.  Genetic alterations of PTEN in human melanoma.

Authors:  Almass-Houd Aguissa-Touré; Gang Li
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

3.  Compound heterozygosity for Pten and SHIP augments T-dependent humoral immune responses and cytokine production by CD(4+) T cells.

Authors:  J L Moody; F R Jirik
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

4.  Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations.

Authors:  Andreas Zettl; Thomas Rüdiger; Maria-Anette Konrad; Andreas Chott; Ingrid Simonitsch-Klupp; Ruth Sonnen; Hans Konrad Müller-Hermelink; German Ott
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

5.  Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells.

Authors:  Steven J Bensinger; Patrick T Walsh; Jidong Zhang; Martin Carroll; Ramon Parsons; Jeffrey C Rathmell; Craig B Thompson; Matthew A Burchill; Michael A Farrar; Laurence A Turka
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

6.  Pten coordinates retinal neurogenesis by regulating Notch signalling.

Authors:  Hong Seok Jo; Kyung Hwa Kang; Cheol O Joe; Jin Woo Kim
Journal:  EMBO J       Date:  2011-12-06       Impact factor: 11.598

7.  E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity.

Authors:  Hui Guo; Guilin Qiao; Haiyan Ying; Zhenping Li; Yixia Zhao; Yanran Liang; Lifen Yang; Stanley Lipkowitz; Josef M Penninger; Wallace Y Langdon; Jian Zhang
Journal:  Cell Rep       Date:  2012-05-31       Impact factor: 9.423

8.  PTEN overexpression suppresses proliferation and differentiation and enhances apoptosis of the mouse mammary epithelium.

Authors:  Joëlle Dupont; Jean Pierre Renou; Moshe Shani; Lothar Hennighausen; Derek LeRoith
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 9.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

10.  Molecular imaging reveals a role for AKT in resistance to cisplatin for ovarian endometrioid adenocarcinoma.

Authors:  Hanxiao Wang; Stefanie Galbán; Rong Wu; Brittany M Bowman; Amanda Witte; Katrin Vetter; Craig J Galbán; Brian D Ross; Kathleen R Cho; Alnawaz Rehemtulla
Journal:  Clin Cancer Res       Date:  2012-10-24       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.